+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Orphan Drug"

Global Markets for Orphan Drugs - Product Thumbnail Image

Global Markets for Orphan Drugs

  • Report
  • January 2024
  • 189 Pages
  • Global
From
Orphan Drugs Market Report 2023-2033 - Product Thumbnail Image

Orphan Drugs Market Report 2023-2033

  • Report
  • October 2023
  • 258 Pages
  • Global
From
Rare Diseases Treatment Global Market Report 2024 - Product Thumbnail Image

Rare Diseases Treatment Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Orphan Drugs Global Market Report 2024 - Product Thumbnail Image

Orphan Drugs Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Orphan Drugs: Global Strategic Business Report - Product Thumbnail Image

Orphan Drugs: Global Strategic Business Report

  • Report
  • March 2024
  • 261 Pages
  • Global
From
From
From
From
From
Global Orphan Drugs Market 2023-2027 - Product Thumbnail Image

Global Orphan Drugs Market 2023-2027

  • Report
  • March 2023
  • 171 Pages
  • Global
From
From
From
From
From
Global IV & Oral Iron Drugs Market - Focused Insights 2024-2029 - Product Thumbnail Image

Global IV & Oral Iron Drugs Market - Focused Insights 2024-2029

  • Report
  • February 2024
  • 126 Pages
  • Global
From
Loading Indicator

The Orphan Drug market is a subset of the Pharmaceutical industry that focuses on the development and commercialization of drugs for rare diseases. These drugs are typically developed to treat diseases that affect fewer than 200,000 people in the United States. The Orphan Drug Act of 1983 was passed to incentivize the development of these drugs by providing tax credits, grants, and other incentives to companies that develop them. The Orphan Drug market has grown significantly in recent years, with more companies entering the market and more drugs being developed. This growth has been driven by advances in medical technology, increased public awareness of rare diseases, and the availability of government incentives. Some companies in the Orphan Drug market include AbbVie, Amgen, Biogen, Gilead Sciences, and Novartis. Show Less Read more